Comparison of ultrarapid and rapid intravenous hydration in pediatric patients with dehydration

Alan L Nager1, Vincent J Wang

  • 1Department of Pediatrics, Division of Emergency and Transport Medicine, Children's Hospital Los Angeles, University of Southern California and the Keck School of Medicine, Los Angeles, CA, USA. anager@chla.usc.edu

Insights

Ultrarapid intravenous (IV) hydration for 1 hour is a safe and effective alternative to standard 3-hour IV hydration for pediatric acute gastroenteritis. This faster method improves emergency department efficiency.

Area of Science:

  • Pediatric Emergency Medicine
  • Gastroenterology
  • Critical Care

Background:

  • Acute gastroenteritis is a common cause of dehydration in children.
  • Moderate dehydration often requires intravenous (IV) fluid resuscitation.
  • Current IV hydration protocols can be time-consuming.

Purpose of the Study:

  • To compare the efficacy of ultrarapid (1-hour) versus standard (3-hour) IV hydration in pediatric patients with acute gastroenteritis and moderate dehydration.
  • To assess the impact on rehydration success, patient outcomes, and emergency department throughput.

Main Methods:

  • A randomized pilot study involving pediatric patients (3-36 months) with moderate dehydration after failing oral rehydration.
  • Patients received either ultrarapid (50 mL/kg over 1 hour) or standard (50 mL/kg over 3 hours) normal saline infusion.
  • Outcomes included rehydration success, return visits, hospital admissions, and laboratory values.

Main Results:

  • No significant difference in rehydration success or serious complications between groups.
  • Ultrarapid hydration showed a trend towards fewer treatment failures and hospitalizations.
  • Both hydration methods were well-tolerated with similar laboratory results.

Conclusions:

  • Ultrarapid IV hydration is a potentially efficacious alternative to standard 3-hour hydration for pediatric gastroenteritis.
  • This approach may improve emergency department efficiency and patient flow.
  • Further research is warranted to confirm these preliminary findings.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...